ClinicalTrials.Veeva

Menu

Description of an Immune Activation Profile Linked to Insulin Resistance in Subjects Aged 55-69 (METACTIV)

C

Centre Hospitalier Universitaire de Nīmes

Status

Completed

Conditions

Insulin Resistance
Metabolic Syndrome X

Treatments

Other: Blood test

Study type

Observational

Funder types

Other

Identifiers

NCT03309761
2017-A01504-49 (Other Identifier)
NIMAO/2016-02/PC-01

Details and patient eligibility

About

The aim of the study is to describe an immune activation profile of people at risk of insulin resistance based on a wide range of markers which will allow easy identification of patients at risk.

Enrollment

158 patients

Sex

All

Ages

55 to 69 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • The patient has been informed of the study, its objectives, constraints and the patient rights
  • The patient must have given their free and informed consent and signed the consent form
  • The patient is aged 55-69

Exclusion criteria

  • The subject is participating in an interventional category 1 study
  • The patient has participated in another category 1 interventional study in the last 3 months
  • The patient is in a period of exclusion determined by a previous study
  • The patient is under safeguard of justice or state guardianship
  • The subject refuses to sign the consent
  • The subject does not understand the information

Trial design

158 participants in 1 patient group

Patients aged 55-60
Treatment:
Other: Blood test

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems